HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fékété, F. Articles by Flejou, J.-F. Search for Related Content PubMed PubMed Citation Articles by Fékété, F. Articles by Flejou, J.-F.

Ann Thorac Surg 1994;58:837-842
© 1994 The Society of Thoracic Surgeons

---

Articles

Associated primary esophageal and lung carcinoma: A study of 39 patients

Departments of Digestive Surgery and Pathology, Hôpital Beaujon, Université Paris VII, Paris, France

Accepted for publication February 1, 1994.

^_* Address reprint requests to Dr Fékété, Service de Chirurgie Digestive, Hôpital Beaujon, 100 Boulevard du Général Leclerc, 92118 Clichy, Paris, France.

From 1979 to 1992, of 1,294 patients with esophageal squamous cell carcinoma, 39 patients (3.2%) (38 male patients, 1 female patient; mean age, 58 years) had associated primary lung carcinoma. Criteria for the diagnosis of primary lung carcinoma were: (1) non-squamous cell carcinoma tumors, (2) tumors existing before the esophageal squamous cell carcinoma, and (3) solitary squamous cell carcinoma presenting with endobronchial involvement. The two tumors were observed synchronously in 22 patients (56%) and metachronously in 17, with a mean tumor-free interval of 46 months (range, 18 to 77 months). In patients with synchronous disease, 10 underwent nonoperative treatment or a palliative surgical procedure, and 12 (55%) underwent a curative operation. In patients with metachronous disease, a curative operation was performed in all for the first tumor and in 9 (53%) for the second tumor. The overall postoperative mortality rate was 15%. Two patients (10%) died after the curative operation. None of the patients died who underwent curative esophagectomy combined with lobectomy. For the patients with synchronous disease, the 5-year survival rate was 11% in those who underwent a curative operation, and the longest survival in those who received palliative treatment was 18 months. For the patients with metachronous disease, the 5-year survival rates from the date of the diagnosis of the second tumor were 17% for those who had a curative operation and 11% for those who received palliative treatment. We conclude that a curative surgical procedure for the management of associated primary esophageal squamous cell and lung carcinoma can be performed in approximately 50% of the patients, and is associated with a low operative mortality and an acceptable long-term survival.

This article has been cited by other articles:

				K. Shien, M. Yamashita, M. Okazaki, H. Suehisa, S. Sawada, and S. Miyoshi Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 1002 - 1006. [Abstract] [Full Text] [PDF]

				Y. Tachimori Cancer Screening in Patients with Cancer Jpn. J. Clin. Oncol., April 1, 2002; 32(4): 118 - 119. [Full Text] [PDF]

				K. Kuhn, S. Pasch, W. Wojciechowski, and P. Macchiarini COMBINED SLEEVE LOBECTOMY AND IVOR LEWIS ESOPHAGECTOMY FOR SYNCHRONOUS PRIMARY CARCINOMA OF THE LUNG AND BARRETT ESOPHAGUS J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1289 - 1290. [Full Text] [PDF]

				M. J. Reardon, A. L. Estrera, L. D. Conklin, P. R. Reardon, F. C. Brunicardi, and A. C. Beall Esophagectomy after pneumonectomy: a surgical challenge Ann. Thorac. Surg., January 1, 2000; 69(1): 286 - 288. [Abstract] [Full Text] [PDF]